Regulation of central dopamine-2 receptor sensitivity by a proportional control thermostat in humans

Psychiatry Research

Volumn 127, Issue 1-2, 2004, Pages 19-26

  Schwartz, Paul J ^a   Erk, Stanley D ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Circadian; Melatonin; Schizophrenia; Striatum; Thermoregulation

Indexed keywords

BROMOCRIPTINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MELATONIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOTHERMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; REGULATORY MECHANISM; SLEEP; STATISTICAL SIGNIFICANCE; TEMPERATURE DEPENDENCE; THERMOREGULATION;

ADOLESCENT; ADULT; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; BROMOCRIPTINE; CIRCADIAN RHYTHM; CORPUS STRIATUM; DOPAMINE AGONISTS; FEMALE; HUMANS; HYPOTHERMIA; MALE; MELATONIN; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA;

EID: 3142770510     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2004.03.004     Document Type: Article

References (53)

1. Abi-Dargham A., Gil R., Krystal J., Baldwin R.M., Seibyl J.P., Bowers M. Increased striatal dopamine transmission in schizophrenia: confirmation in second cohort. American Journal of Psychiatry. 155:1998;761-767
2. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., Weiss R., Cooper T.B., Mann J.J., Van Heertum R.L., Gorman G.M., Laruelle M. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;8104-8109
3. Boulay D., Depoortere R., Perrault G., Borrelli E., Sanger D.J. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Neuropharmacology. 38:1999;1389-1396
4. Breier A., Su T.-P., Saunders R., Carson R.E., Kolachana B.S., deBartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence for a novel positron emission tomography method. Proceedings of the National Academy of Sciences of the United States of America. 94:1997;2569-2574
5. Brown S.J., Gisolfi C.V., Mora F. Temperature regulation and dopaminergic systems in the brain: does the substantia nigra play a role? Brain Research. 234:1982;275-286
6. Brown E.N., Choe Y., Shanahan T.L., Czeisler C.A. A mathematical model of diurnal variations in human plasma melatonin levels. American Journal of Physiology. 35:1997;E506-E516
7. 3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochemistry International. 30:1997;565-574
8. Chipkin R.E. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats. Pharmacology, Biochemistry and Behavior. 30:1988;683-686
9. Coldwell M.C., Boyfield I., Brown T., Hagan J.J., Middlemiss D.N. Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells. British Journal of Pharmacology. 127:1999;1696-1702
10. Cutler N.R., Post R.M., Bunney W.E. Jr. Apomorphine-induced hypothermia: an index of central dopamine receptor function in man. Communications in Psychopharmacology. 3:1979;375-382
11. Daan S., Masman D., Strijkstra A., Verhulst S. Intra-specific allometry of basal metabolic rate: relations with body size, temperature, composition and circadian phase in the Kestrel, Falco tinnunculus. Journal of Biological Rhythms. 4:1989;267-283
12. Fanget F., Claustrat B., Dalery J., Brun J., Terra J.-L., Marie-Cardine M., Guyotat J. Nocturnal plasma melatonin levels in schizophrenic patients. Biological Psychiatry. 25:1989;499-501
13. Ferrier I.N., Arendt J., Johnstone E.C., Crow T.J. Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight. Clinical Endocrinology. 17:1982;181-187
14. Gardner B., Strange P.G. Agonist action at D2(long) dopamine receptors: ligand binding and functional assays. British Journal of Pharmacology. 124:1998;978-984
15. Gardner B.R., Hall D.A., Strange P.G. Agonist action at D2(short) dopamine receptors determined in ligand binding and functional assays. Journal of Neurochemistry. 69:1997;2589-2598
16. Glick S.D., Marsanico R.G. Apomorphine-induced and pilocarpine-induced hypothermia in mice: drug interactions and changes after caudate nucleus lesions. British Journal of Pharmacology. 51:1974;353-357
17. Glotzbach S.F., Heller H.C. Central nervous regulation of body temperature during sleep. Science. 194:1976;537-539
18. Gurevich E.V., Joyce J.N. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study. Biological Psychiatry. 42:1997;529-545
19. Hammel H.T. Regulation of internal body temperature. Annual Review of Physiology. 30:1968;641-710
20. 1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sciences. 48:1991;355-363
21. Heller H.C., Colliver G.W. CNS regulation of body temperature in euthermic hibernators. American Journal of Physiology. 227:1974;576-582
22. Kahn R.S., Siever L.J., Gabriel S., Amin F., Stern R.G., DuMont K., Apter S., Davidson M. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects. Psychiatry Research. 43:1992;1-12
23. Khaldy H., León J., Escames G., Bikjdaouene L., Garcia J.J., Acuña-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology. 75:2002;201-208
24. 1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity. Brain Research. 782:1998;1-10
25. Laruelle M. Imaging dopamine transmission in schizophrenia. Quarterly Journal of Nuclear Medicine. 42:1998;211-221
26. Laurelle M., Abi-Dargham A., Van Dyck C.H., Gil R., De Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenia subjects. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;9235-9240
27. Lee T.F., Mora F., Myers R.D. Dopamine and thermoregulation: an evaluation with special reference to dopaminergic pathways. Neuroscience and Biobehavioral Reviews. 9:1985;589-598
28. Lee H.S., Bastani B., Friedman L., Ramirez L., Meltzer H.Y. Effect of the serotonin agonist, MK-212, on body temperature in schizophrenia. Biological Psychiatry. 31:1992;460-470
29. Lin M.T., Chandra A., Tsay B.L., Chern Y.F. Hypothalamic and striatal dopamine receptor activation inhibits heat production in the rat. American Journal of Physiology. 242:1982;R471-R481
30. Lin M.T., Ho M.T., Young M.S. Stimulation of the nigrostriatal dopamine system inhibits both heat production and heat loss mechanisms in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 346:1992;504-510
31. Mierau J., Schneider F.J., Ensinger H.A., Chio C.L., Lajiness M.E., Huff R.M. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. European Journal of Pharmacology. 290:1995;29-36
32. 2 receptors elicits prolactin secretion and catalepsy. Journal of Pharmacology and Experimental Therapeutics. 275:1995;885-898
33. Millan M.J., Maiofiss L., Cussac D., Audinot V., Boutin J.-A., Newman-Tancredi A. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. Journal of Pharmacology and Experimental Therapeutics. 303:2002;791-804
34. Monteleone P., Maj M., Fusco M., Kemali D., Reiter R. Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophrenia Research. 7:1992;77-84
35. Monteleone P., Natale M., La Rocca A., Maj M. Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology. 36:1997;159-163
36. Nunes J.L., Sharif N.A., Michel A.D., Whiting R.L. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochemistry Research. 16:1991;1167-1174
37. 3 receptors. European Journal of Pharmacology. 366:1999;293-300
38. Perachon S., Betaneur C., Piln C., Rostene W., Schwartz J.C., Sokoloff P. Role of dopamine D3 receptors in thermoregulation: a reappraisal. NeuroReport. 11:2000;221-225
39. Rao M.L., Gross G., Strebel B., Halaris A., Huber G., Bräunig P., Marler M. Circadian rhythm of tryptophan, serotonin, melatonin and pituitary hormones in schizophrenia. Biological Psychiatry. 35:1994;151-163
40. Satinoff E. Neural organization and evolution of thermal regulation in mammals. Science. 201:1978;16-22
41. Sautel F., Griffon N., Lévesque D., Schwartz J.-C., Sokoloff P. A functional test identifies dopamine agonists selective for D3 vs. D2 receptors. NeuroReport. 6:1995;329-332
42. Schwartz P.J., Wehr T.A., Rosenthal N.E., Bartko J.J., Oren D.A., Luetke C., Murphy D.L. Serotonin and thermoregulation: physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects. Neuropsychopharmacology. 13:1995;105-115
43. Schwartz P.J., Murphy D.L., Wehr T.A., Garcia-Borreguero D., Oren D.A., Moul D.E., Ozaki N., Snelbaker A.J., Rosenthal N.E. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy controls: diurnal responses and nocturnal regulatory mechanisms. Archives of General Psychiatry. 54:1997;375-385
44. Schwartz P.J., Rosenthal N.E., Wehr T.A. Serotonin 1A receptors, melatonin and the proportional control thermostat in patients with winter depression. Archives of General Psychiatry. 55:1998;897-903
45. 2 receptors. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;7673-7675
46. Shanahan T.L., Kronauer R.E., Duffy J.F., Williams G.H., Czeisler C.A. Melatonin rhythm observed throughout a three-cycle bright-light stimulus designed to reset the human circadian pacemaker. Journal of Biological Rhythms. 14:1999;237-253
47. 3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia. Biological Psychiatry. 39:1996;919-928
48. Soares J.C., Innis R.B. Neurochemical brain imaging investigations of schizophrenia. Biological Psychiatry. 46:1999;600-615
49. 1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Research. 708:1996;209-214
50. Torrey E.F., Miller J., Rawlings R., Yolken R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophrenia Research. 28:1997;1-38
51. Vigano D., Lissoni P., Rovelli F., Roselli M.G., Malugani F., Gavazzeni C., Conti A., Maestroni G. A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia. Neuroendocrinology Letters. 22:2001;137-141
52. 4 receptor ligands: relation to antipsychotic action. European Journal of Pharmacology. 351:1998;273-286
53. 2 dopamine receptors in schizophrenia; the ups and downs of neuroimaging research. Archives of General Psychiatry. 59:2002;31-34